BioNano Genomics Inc vs HSBC Holdings plc — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while HSBC Holdings plc trades at $104.04 (market cap $353.82B). The key difference: HSBC Holdings plc is far larger — about 25901.9× BioNano Genomics Inc's market cap, and HSBC Holdings plc pays a 3.63% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | HSBC | |
|---|---|---|
Market Cap | $13.66M | $353.82B |
Sector | Health | Technology |
52-Week High | $4.92 | $107.86 |
52-Week Low | $1.06 | $63.84 |
Enterprise Value | $16.26M | — |
Dividend Yield | — | 3.63% |
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →